Characteristics and molecular basis of celecoxib modulation on Kv7 potassium channels
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
BACKGROUND AND PURPOSE: Celecoxib is a selective cyclooxygenase‐2 (COX‐2) inhibitor used for the treatment of pain and inflammation. Emerging and accumulating evidence suggests that celecoxib can affect cellular targets other than COX, such as ion channels. In this study, we characterized the effects of celecoxib on K v 7 K+ channels and compared its effects with the well‐established K v 7 channel opener retigabine. EXPERIMENTAL APPROACH: A perforated whole‐cell patch technique was used to record K v 7currents expressed in HEK 293 cells and M‐type currents from rat superior cervical ganglion neurons. KEY RESULTS: Celecoxib enhanced K v 7.2–7.4, K v 7.2/7.3 and K v 7.3/7.5 currents but inhibited K v 7.1 and K v 7.1/KCNE1 currents and these effects were concentration dependent. The IC 50 value for inhibition of K v 7.1 channels was approximately 4 µM and the EC 50 values for activation of K v 7.2–7.4, K v 7.2/K v 7.3 and K v 7.3/K v 7.5 channels were approximately 2–5 µM. The effects of celecoxib were manifested by increasing current amplitudes, shifting the voltage‐dependent activation curve in a more negative direction and slowing the deactivation of K v 7 currents. 2,5‐Dimethyl‐celecoxib, a celecoxib analogue devoid of COX inhibition activity, has similar but greater effects on K v 7currents. K v 7.2(A235T) and K v 7.2(W236L) mutant channels, which have greatly attenuated responses to retigabine, showed a reversed response to celecoxib, from activation to inhibition. CONCLUSIONS AND IMPLICATIONS: These results suggest that K v 7 channels are targets of celecoxib action and provide new mechanistic evidence for understanding the effects of celecoxib. They also provide a new approach to developing K v 7 modulators and for studying the structure–function relationship of K v 7 channels.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Guide to receptors and channels (GRAC), 5th edition
Alexander, S., Mathie, A., & Peters, J. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01649_1.x · Cited by 1,947
Brown, D. A., & Passmore, G. M. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00111.x · Cited by 676 · cited 3×
“nervous system (Jentsch, 2000; Robbins, 2001) and contribute differentially to neuronal M-type currents, depending on the location (Brown and Passmore, 2009).”
BackgroundClinical Pharmacokinetics and Pharmacodynamics of Celecoxib: A Selective Cyclo-Oxygenase-2 Inhibitor
Davies, N. M., McLachlan, A. J., Day, R. O., & Williams, K. M. (2000) · Clinical Pharmacokinetics · doi:10.2165/00003088-200038030-00003 · Cited by 424
Meta-analysis of Cyclooxygenase-2 Inhibitors and Their Effects on Blood Pressure
(2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.5.ioi50013 · Cited by 329
Shapiro, M. S., Roche, J. P., Kaftan, E. J., Cruzblanca, H., Mackie, K., & Hille, B. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-05-01710.2000 · Cited by 201 · cited 1×
“3 subunits (Wang et al., 1998; Hadley et al., 2000; Shapiro et al., 2000).”
Cited by
Chemical modulation of Kv7 potassium channels
Borgini, M., Mondal, P., Liu, R., & Wipf, P. (2021) · RSC Medicinal Chemistry · doi:10.1039/d0md00328j · Cited by 37
Ray, S., Salzer, I., Kronschläger, M. T., & Boehm, S. (2019) · Pain · doi:10.1097/j.pain.0000000000001474 · Cited by 35
Wang, H., Qiao, Z., Luan, K., Xiang, W., Chang, X., Zhang, Y., Wei, N., & Wang, K. (2024) · Epilepsia · doi:10.1111/epi.18092 · Cited by 16
Carotenuto, L., Keminer, O., Carleo, G., Zaliani, A., Leo, A., Citraro, R., De Sarro, G., Dirkx, N., Kaji, M., Weckhuysen, S., et al. (2025) · British Journal of Pharmacology · doi:10.1111/bph.70119 · Cited by 10
Lemke, J., Gollasch, M., Tsvetkov, D., & Schulig, L. (2025) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2024.2438226 · Cited by 6
Metadata
- Authors
- Du, X., Zhang, X., Qi, J., An, H., Li, J., Wan, Y., Fu, Y., Gao, H., Gao, Z., Zhan, Y., & Zhang, H.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2011-10-24
- Volume
- 164
- Issue
- 6
- Pages
- 1722-1737
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W1555070716
- Cited by
- 41
- References
- 5
- FWCI
- 1.29
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Characteristics and molecular basis of celecoxib modulation on Kv7 potassium channels. https://app.cochat.ai/papers/10.1111/j.1476-5381.2011.01483.x
- The paper
- Du, X., Zhang, X., Qi, J., An, H., Li, J., Wan, Y., Fu, Y., Gao, H., Gao, Z., Zhan, Y., & Zhang, H. (2011). Characteristics and molecular basis of celecoxib modulation on Kv7 potassium channels. British Journal of Pharmacology. https://doi.org/10.1111/j.1476-5381.2011.01483.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.